Cotta Ramusino, Matteo http://orcid.org/0000-0003-3090-9648
Perini, Giulia
Altomare, Daniele
Barbarino, Paola
Weidner, Wendy
Salvini Porro, Gabriella
Barkhof, Frederik
Rabinovici, Gil D.
van der Flier, Wiesje M.
Frisoni, Giovanni B.
Garibotto, Valentina
Teipel, Stefan
Boccardi, Marina
Funding for this research was provided by:
Swiss National Science Foundation (320030_169876)
Innovative Medicines Initiative 2 Joint Undertaking (115952)
Article History
Received: 13 October 2020
Accepted: 28 December 2020
First Online: 17 February 2021
Compliance with ethical standards
:
: V. Garibotto received financial support for research through her institution from Siemens Healthineers, GE Healthcare, Life Molecular Imaging, Cerveau Technologies, Roche, Merck. G.D. Rabinovici receives research support from the National Institutes of Health, Alzheimer’s Association, American College of Radiology, Rainwater Charitable Foundation, Gift from Edward and Pearl Fein, Avid Radiopharamaceuticals, Eli Lilly, Life Molecular Imaging, GE Healthcare. He has served as a consultant for Axon Neurosciences, Eisai, GE Healthcare, Merck, Genentech. He serves on a data safety monitoring board for Johnson & Johnson. He is an Associate Editor for JAMA Neurology.F. Barkhof is a member of steering committee and safety monitoring boards for Merck, Biogen and Bayer. He is a consultant for Novartis, Roche, IXICO, GeNeuro, and Combinostics; his institutions received research support from EU/EFPIA Innovative Medicines Initiative Joint Undertaking (EPAD and AMYPAD consortia), Horizon (EuroPOND), UK MS Society, IMDI-NOW (PICTURE), NIHR UCLH Biomedical Research Centre, and ECTRIMS-MAGNIMS. He is section Editor for Neuroradiology. The other authors declare that they have no conflict of interest.
: Not applicable (the work did not involve human nor animal participants)
: Not applicable
: Not applicable
: Not applicable